Sunesis Pharmaceuticals to Host Conference Call on August 7th to Discuss Second Quarter 2019 Financial Results and Recent Hig...
July 31 2019 - 7:00AM
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that
it will host a conference call on Wednesday, August 7th, 2019 at
4:30 p.m. Eastern Time to discuss corporate updates and financial
results for the second quarter ended June 30, 2019.
The call can be accessed by dialing (844)
296-7720 (U.S. and Canada) or (574) 990-1148 (International) and
entering passcode 2686126.
To access the live audio webcast, or the
subsequent archived recording, visit the "Investors and Media -
Calendar of Events" section of the Sunesis website at
http://ir.sunesis.com. The webcast will be recorded and available
for replay on the company's website for two weeks.
About Sunesis
Pharmaceuticals
Sunesis is a biopharmaceutical company
developing novel targeted inhibitors for the treatment of
hematologic and solid cancers. Sunesis has built an experienced
drug development organization committed to improving the lives of
people with cancer. The Company is focused on advancing its novel
kinase inhibitor pipeline, with an emphasis on its oral
non-covalent BTK inhibitor vecabrutinib. Vecabrutinib is currently
being evaluated in a Phase 1b/2 study in adults with chronic
lymphocytic leukemia and other B-cell malignancies that have
progressed after prior therapies.
For additional information on Sunesis, please
visit www.sunesis.com.
SUNESIS and the logos are trademarks of Sunesis
Pharmaceuticals, Inc.
Investor and Media Inquiries:Maeve ConneightonArgot
Partners212-600-1902
Willie QuinnSunesis Pharmaceuticals Inc.650-266-3716
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2023 to Sep 2024